In a humanized mouse model of lung cancer, vaccination with iPSCs and CpG led to an increase in splenic APCs, cytotoxic T cells, circulating effector/memory CD4+ and CD8+ T cells, and tumor-infiltrating CD8+ T cells, while reducing regulatory T cells (Tregs). This evidence concerns the gene CD8A and lung carcinoma.